Platelet rich plasma is plasma with more platelets than what is typically found in blood. To develop a plasma rich platelet preparation, blood must first be drawn from a patient. The platelets are separated from other blood cells and their concentration is increased during a process called centrifugation, after that the increased concentration of platelets is combined with remaining blood. Platelet rich plasma has a strong effect in the early phase of healing. Furthermore, platelet rich plasma is used for ligament and tendon injuries, knee osteoarthritis, degenerative knee cartilage and chronic elbow necessities, muscle strain and tears.
In 2014, the global platelet rich plasma market was valued at USD 140.0 million, while in 2015, the market size of global platelet rich plasma market surpassed USD 155 million. The global platelet rich plasma market is projected to grow with a CAGR between 12 % and 13% during 2016-2022 and reach USD XXX million by 2022.
Increasing chronic disease population, increasing number patients suffering with orthopedic injuries, rising number of cosmetic surgeries, and increasing awareness about benefits associated with platelet rich plasma are key factors driving the growth of this market over forecast period. However, high cost associated with medical devices used for treatment and threats associated with PRP therapy are the key restraining factors affecting the growth of global platelet rich plasma market. Nevertheless, growing geriatric population and development of new applications of PRP technologies are likely to bring more opportunities to this market for major players and new entrants.
The report segments the platelet rich plasma market by source and by application. The market segmentation based on source includes autologous, homologous, and allogenic. Moreover, based on application the global platelet rich plasma market is segmented into orthopedic surgery, cosmetic surgery, general surgery, neurosurgery and other surgeries (urology, cardiothoracic, oral and maxillofacial and periodontal). Cosmetic surgery is the fastest growing segment in global platelet rich plasma market due to increasing awareness among people about better appearance and for enhancing personality.
Geographic Coverage and Analysis:
The report provides regional analysis covering geographies such as North America, Europe, Asia Pacific, Latin America and Rest of the World (RoW). North America is accounted as the largest growing region and majority share in 2015 supported by increasing number of orthopedic and cosmetic surgeries. Furthermore, presence of leading market players in the region and increasing awareness among the people about PRP therapy will continue the dominance of North America over the forecast period. However, Asia Pacific is expected to witness a healthy growth in the market due to rise in PRP therapy in the region. Further, increasing number of medical devices as well as highly developing healthcare infrastructure in the region is expected to accelerate growth in this market by 2022. Moreover, rising demand of cosmetic surgeries, increasing awareness among sports players about platelet rich plasma therapies in the emerging markets of Asia are anticipated to grow PRP market in the region at the highest CAGR over the forecast period.
The companies covered in the report include Harvest Technologies Corporation, Arthrex, Inc., Estar Technologies Ltd.Zimmer Biomet, DePuy Synthes, Inc, Stryker Corporation, AdiStem Ltd., Cesca Therapeutics, Inc., Eclipse Aesthetics, LLC.Emcyte Corporation, Nuo Therapeutics, Regen Lab SA, Exactech Inc., and Others.
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of platelet rich plasma globally as well as regionally. Moreover, the Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider.
The report provides insights into the market using analytical tools such as Porter’s five forces analysis and value chain analysis of platelet rich plasma market. Moreover, the study highlights current market trends and provides forecast from 2016 to 2022. We also have highlighted future trends in the platelet rich plasma market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market. This report will help manufacturers, suppliers and distributors of the platelet rich plasma market to understand the present and future trends in this market and formulate their strategies accordingly.
1.1 Report Description
1.1.1 Segmentation and Research Scope
1.2 Research Methodology
22.214.171.124 Primary Research
126.96.36.199 Secondary Research
1.2.2 Data Collection Matrix
1.3 Research Approaches
2 Executive Summary
2.1 Global Platelet Rich Plasma Market Highlights, (USD Million)
2.2 Global Platelet Rich Plasma Market Projection, 2015-2021 (USD Million)
2.3 Global Platelet Rich Plasma Market Cagr Growth By Regions
3 Market Overview And Competitiveness
3.1 DRO Analysis
188.8.131.52 Driver 1
184.108.40.206 Driver 2
220.127.116.11 Restraint 1
3.2 Porter’s Five Foreces Analysis
3.2.1 Buyer Power
3.2.2 Supplier Power
3.2.3 Competitive Rivalry
3.2.4 Threat of Substitution
3.2.5 Threat of New Entry
4 Global Platelet Rich Plasma Market Infograph
5 Global Platelet Rich Plasma Market By Source Type
6 Global Platelet Rich Plasma Market By Applications
6.2 Orthopedic Surgery
6.3 Cosmetic Surgery
6.4 General Surgery
7 Global Platelet Rich Plasma Market, By Geography
7.1.1 Global Platelet Rich Plasma Market By Region
7.2 North America Platelet Rich Plasma Market
7.2.1 North America Platelet Rich Plasma Market By Source Type
7.2.2 North America Platelet Rich Plasma Market By Application
7.3 Europe Platelet Rich Plasma Market
7.3.1 Europe Platelet Rich Plasma Market By Source Type
7.3.2 Europe Platelet Rich Plasma Market By Application
7.4 Asia-Pacific Platelet Rich Plasma Market
7.4.1 Asia-Pacific Platelet Rich Plasma Market By Source Type
7.4.2 Asia-Pacific Platelet Rich Plasma Market By Application
7.5 Row Platelet Rich Plasma Market
7.4.1 Row Platelet Rich Plasma Market By Source Type
7.4.2 Row Platelet Rich Plasma Market By Application
8 Company Profiles
8.2 Harvest Technologies Corporation
8.2.1 Harvest Technologies Corporation: Contact Info
8.2.2 Harvest Technologies Corporation: Financial Info
8.2.3 Harvest Technologies Corporation: SWOT Analysis
8.2.4 Harvest Technologies Corporation: Product Portfolio
8.2.5 Recent Developments of Harvest Technologies Corporation
8.3 Arthrex, Inc.
8.3.1 Arthrex, Inc.: Contact Info
8.3.2 Arthrex, Inc.: Financial Info
8.3.3 Arthrex, Inc.: SWOT Analysis
8.3.4 Arthrex, Inc.: Product Portfolio
8.3.5 Recent Developments of Arthrex, Inc.
8.4 Zimmer Biomet
8.4.1 Zimmer Biomet: Contact Info
8.5.2 Zimmer Biomet: Financial Info
8.4.3 Zimmer Biomet: SWOT Analysis
8.4.4 Zimmer Biomet: Product Portfolio
8.4.5 Recent Developments of Zimmer Biomet
8.5 Depuy Synthes, Inc
8.5.1 Depuy Synthes, Inc: Contact Info
8.5.2 Depuy Synthes, Inc: Financial Info
8.5.3 Depuy Synthes, Inc: SWOT Analysis
8.5.4 Depuy Synthes, Inc: Product Portfolio
8.5.5 Recent Developments of Depuy Synthes, Inc
8.6 Stryker Corporation
8.6.1 Stryker Corporation: Contact Info
8.6.2 Stryker Corporation: Financial Info
8.6.3 Stryker Corporation: SWOT Analysis
8.6.4 Stryker Corporation: Product Portfolio
8.6.5 Recent Developments of Stryker Corporation
8.6 Adistem Ltd.
8.6.1 Adistem Ltd.: Contact Info
8.6.2 Adistem Ltd.: Financial Info
8.6.3 Adistem Ltd.:SWOT Analysis
8.6.4 Adistem Ltd.: Product Portfolio
8.6.5 Recent Developments of Adistem Ltd.
8.6 Cesca Therapeutics, Inc.
8.6.1 Cesca Therapeutics, Inc.: Contact Info
8.6.2 Cesca Therapeutics, Inc.: Financial Info
8.6.3 Cesca Therapeutics, Inc.:SWOT Analysis
8.6.4 Cesca Therapeutics, Inc.: Product Portfolio
8.6.5 Recent Developments of Cesca Therapeutics, Inc.
8.7 Emcyte Corporation.
8.7.1 Emcyte Corporation.: Contact Info
8.7.2 Emcyte Corporation.: Financial Info
8.7.3 Emcyte Corporation:SWOT Analysis
8.7.4 Emcyte Corporation: Product Portfolio
8.7.5 Recent Developments of Emcyte Corporation
8.8 Nuo Therapeutics
8.8.1 Nuo Therapeutics: Contact Info
8.8.2 Nuo Therapeutics.: Financial Info
8.8.3 Nuo Therapeutics:SWOT Analysis
8.8.4 Nuo Therapeutics: Product Portfolio
8.8.5 Recent Developments of Nuo Therapeutics
8.9 Regen Lab SA
8.9.1 Regen Lab SA.: Contact Info
8.9.2 Regen Lab SA.: Financial Info
8.9.3 Regen Lab SA: SWOT Analysis
8.9.4 Regen Lab SA: Product Portfolio
8.9.5 Recent Developments of Regen Lab SA
8.10 Exactech Inc.
8.10.1 Exactech Inc.: Contact Info
8.10.2 Exactech Inc.: Financial Info
8.10.3 Exactech Inc.:SWOT Analysis
8.10.4 Exactech Inc.: Product Portfolio
8.10.5 Recent Developments of Exactech Inc.
- AdiStem Ltd.
- Arthrex, Inc.
- Cesca Therapeutics, Inc.
- DePuy Synthes, Inc
- Eclipse Aesthetics, LLC.
- Emcyte Corporation
- Estar Technologies Ltd.
- Exactech Inc.
- Harvest Technologies Corporation
- Nuo Therapeutics
- Regen Lab SA
- Stryker Corporation
- Zimmer Biomet